Marijuana Research Today is a free monthly online journal that collates and summarizes the latest research about Marijuana, including details on benefits, cancer, effects, uses, addiction.

Volume 8 (2011), Issue 5 (May)

1. Pubertal Timing and Substance Use in Middle Adolescence: A 2-Year Follow-up Study.
   J Youth Adolesc. [Abstract] [Full-text]
2. Cannabis use in patients with fibromyalgia: effect on symptoms relief and health-related quality of life.
   PLoS One, 6(4): e18440. [Abstract] [Full-text]
3. Motivational interviewing to reduce substance-related consequences: Effects for incarcerated adolescents with depressed mood.
   Drug Alcohol Depend. [Abstract] [Full-text]
4. Cannabis use in young people: The risk for schizophrenia.
   Neurosci Biobehav Rev. [Abstract] [Full-text]
5. The hypothermic response to bacterial lipopolysaccharide critically depends on brain CB1, but not CB2 or TRPV1, receptors.
   J Physiol, 589: 2415-31. [Abstract] [Full-text]
6. Psychotropic and nonpsychotropic cannabis derivatives inhibit human 5-HT(3A) receptors through a receptor desensitization-dependent mechanism.
   Neuroscience. [Abstract] [Full-text]
7. Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia.
   Schizophr Res, 128(1): 66-75. [Abstract] [Full-text]
8. The effects of cannabis use on neurocognition in schizophrenia: A meta-analysis.
   Schizophr Res, 128(1): 111-6. [Abstract] [Full-text]
9. Greater white and grey matter changes associated with early cannabis use in adolescent-onset schizophrenia (AOS).
   Schizophr Res, 128(1): 91-7. [Abstract] [Full-text]
10. Cannabis use in patients with fibromyalgia: effect on symptoms relief and health-related quality of life.
    PLoS One, 6(4): e18440. [Abstract] [Full-text]
11. Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia.
    Schizophr Res, 128(1): 66-75. [Abstract] [Full-text]
12. The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis.
    Schizophr Res, 128(1): 111-6. [Abstract] [Full-text]
13. Greater white and grey matter changes associated with early cannabis use in adolescent-onset schizophrenia (AOS).
    Schizophr Res, 128(1): 91-7. [Abstract] [Full-text]
14. Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study.
    Eur J Clin Pharmacol. [Abstract] [Full-text]
15. Gender differences in trait aggression in young adults with drug and alcohol dependence compared to the general population.
    Prog Neuropsychopharmacol Biol Psychiatry. [Abstract] [Full-text]
16. Synergistic pathways to delusions: enduring vulnerabilities, proximal life stressors and maladaptive psychological coping.
    Early Interv Psychiatry, 5(2): 122-31. [Abstract] [Full-text]
17. Characterization of South African Adolescents With Alcohol Use Disorders but Without Psychiatric or Polysubstance Comorbidity.
    Alcohol Clin Exp Res. [Abstract] [Full-text]
18. Racial/ethnic disparities in therapist effectiveness: A conceptualization and initial study of cultural competence.
    J Couns Psychol. [Abstract] [Full-text]
19. Developmental pathways to adolescent cannabis abuse and dependence: Child maltreatment, emerging personality, and internalizing versus externalizing psychopathology.
    Psychol Addict Behav. [Abstract] [Full-text]
20. IDENTIFICATION OF THE GPR55 AGONIST BINDING SITE USING A NOVEL SET OF HIGH POTENCY GPR55 SELECTIVE LIGANDS.
    Biochemistry. [Abstract] [Full-text]
21. Anxiety sensitivity and marijuana use: an analysis from ecological momentary assessment.
    Depress Anxiety, 28(5): 420-6. [Abstract] [Full-text]
22. Synergistic pathways to delusions: enduring vulnerabilities, proximal life stressors and maladaptive psychological coping.
    Early Interv Psychiatry, 5(2): 122-31. [Abstract] [Full-text]
23. Developmental pathways to adolescent cannabis abuse and dependence: Child maltreatment, emerging personality, and internalizing versus externalizing psychopathology.
    Psychol Addict Behav. [Abstract] [Full-text]
24. Anxiety sensitivity and marijuana use: an analysis from ecological momentary assessment.
    Depress Anxiety, 28(5): 420-6. [Abstract] [Full-text]
25. Lower ventral striatal activation during reward anticipation in adolescent smokers.
    Am J Psychiatry, 168(5): 540-9. [Abstract] [Full-text]
26. An analytical evaluation of eight on-site oral fluid drug screening devices using laboratory confirmation results from oral fluid.
    Forensic Sci Int, 208(1): 173-9. [Abstract] [Full-text]
27. THC and CBD oromucosal spray (Sativex(®)) in the management of spasticity associated with multiple sclerosis.
    Expert Rev Neurother, 11(5): 627-37. [Abstract] [Full-text]
28. THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis.
    Expert Rev Neurother, 11(5): 627-37. [Abstract] [Full-text]
29. HON Label and DISCERN as Content Quality Indicators of Health-Related Websites.
    Psychiatr Q. [Abstract] [Full-text]
30. Factors associated with alcohol and drug use among traffic crash victims in southern Brazil.
    Accid Anal Prev, 43(4): 1408-13. [Abstract] [Full-text]
31. Clinical prevalence and correlates of substance use in adolescent psychiatric emergency patients.
    Pediatr Emerg Care, 27(5): 384-9. [Abstract] [Full-text]
32. Prevalence and correlates of waterpipe tobacco smoking by college students in North Carolina.
    Drug Alcohol Depend, 115(1): 131-6. [Abstract] [Full-text]
33. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).
    Drug Alcohol Depend, 115(1): 120-30. [Abstract] [Full-text]
34. An initial trial of a computerized behavioral intervention for cannabis use disorder.
    Drug Alcohol Depend, 115(1): 74-9. [Abstract] [Full-text]
35. Cannabinoids lead to enhanced virulence of the smallpox vaccine (vaccinia) virus.
    Immunobiology, 216(6): 670-7. [Abstract] [Full-text]
36. Enhancing response inhibition by incentive: comparison of adolescents with and without substance use disorder.
    Drug Alcohol Depend, 115(1): 43-50. [Abstract] [Full-text]
37. Measuring pain medication expectancies in adults treated for substance use disorders.
    Drug Alcohol Depend, 115(1): 51-6. [Abstract] [Full-text]
38. DRD2 and DRD4 in relation to regular alcohol and cannabis use among adolescents: does parenting modify the impact of genetic vulnerability? The TRAILS study.
    Drug Alcohol Depend, 115(1): 35-42. [Abstract] [Full-text]
39. Is thromboangiitis obliterans presentation influenced by cannabis addiction?
    Ann Vasc Surg, 25(4): 469-73. [Abstract] [Full-text]
40. Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential.
    Neurosci Lett, 496(1): 60-4. [Abstract] [Full-text]
41. Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action.
    Cell Death Differ, 18(6): 959-73. [Abstract] [Full-text]
42. "CAN Stop"--implementation and evaluation of a secondary group prevention for adolescent and young adult cannabis users in various contexts--study protocol.
    BMC Health Serv Res, 11: 80. [Abstract] [Full-text]
43. The effects of drug-prevention messages on the accessibility of identity-related constructs.
    J Health Commun, 16(5): 458-69. [Abstract] [Full-text]
44. Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews.
    Psychopharmacology (Berl), 215(3): 505-12. [Abstract] [Full-text]
45. Substance use among middle school students: associations with self-rated and peer-nominated popularity.
    J Adolesc, 34(3): 513-9. [Abstract] [Full-text]
46. Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults.
    Int J Neuropsychopharmacol. [Abstract] [Full-text]
47. Joint modeling of longitudinal data in multiple behavioral change.
    Eval Health Prof, 34(2): 181-200. [Abstract] [Full-text]
48. Universal school-based prevention programs for alcohol misuse in young people.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
49. Alcohol and drug use among patients presenting to an inner-city emergency department: a latent class analysis.
    Addict Behav, 36(8): 793-800. [Abstract] [Full-text]
50. Inhalant use initiation among U.S. adolescents: evidence from the National Survey of Parents and Youth using discrete-time survival analysis.
    Addict Behav, 36(8): 878-81. [Abstract] [Full-text]
51. Adverse consequences of student drinking: the role of sex, social anxiety, drinking motives.
    Addict Behav, 36(8): 821-8. [Abstract] [Full-text]
52. Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study.
    Neuropsychopharmacology, 36(7): 1340-8. [Abstract] [Full-text]
53. CP47,497-C8 and JWH073, commonly found in 'Spice' herbal blends, are potent and efficacious CB(1) cannabinoid receptor agonists.
    Eur J Pharmacol, 659(2): 139-45. [Abstract] [Full-text]
54. Quetiapine in adolescents with non-affective psychotic disorders: an open-label trial.
    Pharmacopsychiatry, 44(3): 87-95. [Abstract] [Full-text]
55. Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism.
    Acta Psychiatr Scand, 123(6): 485-92. [Abstract] [Full-text]
56. The validity of DSM-IV cannabis abuse and dependence criteria in adolescents and the value of additional cannabis use indicators.
    Addiction, 106(6): 1137-45. [Abstract] [Full-text]
57. Validation of the Cannabis Expectancy Questionnaire (CEQ) in adult cannabis users in treatment.
    Drug Alcohol Depend, 115(3): 167-74. [Abstract] [Full-text]
58. Depressive symptoms and patterns of drug use among street youth.
    J Adolesc Health, 48(6): 585-90. [Abstract] [Full-text]
59. Tobacco, alcohol and illicit drug use among Aboriginal youth living off-reserve: results from the Youth Smoking Survey.
    CMAJ, 183(8): E480-6. [Abstract] [Full-text]
60. Alcohol, smoking, and drug use among Inuit women of childbearing age during pregnancy and the risk to children.
    Alcohol Clin Exp Res, 35(6): 1081-91. [Abstract] [Full-text]
61. Association of caffeine intake and histological features of chronic hepatitis C.
    J Hepatol, 54(6): 1123-9. [Abstract] [Full-text]
62. Consumption of medicines, alcohol, tobacco and cannabis among university students: a 2-year follow-up.
    Int J Public Health, 56(3): 247-52. [Abstract] [Full-text]
63. Liquid ecstasy intoxication: clinical features of 505 consecutive emergency department patients.
    Emerg Med J, 28(6): 462-6. [Abstract] [Full-text]
64. Substance use by adolescents in special education and residential youth care institutions.
    Eur Child Adolesc Psychiatry, 20(6): 311-9. [Abstract] [Full-text]
65. Patterns of substance use in adolescents attending a mental health department.
    Eur Child Adolesc Psychiatry, 20(6): 279-89. [Abstract] [Full-text]
66. Cannabis use disorder and age at onset of psychosis--a study in first-episode patients.
    Schizophr Res, 129(1): 52-6. [Abstract] [Full-text]
67. Simultaneous analysis of Δ(9)-tetrahydrocannabinol and 11-nor-9-carboxy-tetrahydrocannabinol in hair without different sample preparation and derivatization by gas chromatography-tandem mass spectrometry.
    J Pharm Biomed Anal, 55(5): 1096-103. [Abstract] [Full-text]
68. Psychotropic and nonpsychotropic cannabis derivatives inhibit human 5-HT(3A) receptors through a receptor desensitization-dependent mechanism.
    Neuroscience, 184: 28-37. [Abstract] [Full-text]
69. Female intimate partner violence perpetration: stability and predictors of mutual and nonmutual aggression across the first year of college.
    Aggress Behav, 37(4): 362-73. [Abstract] [Full-text]
70. Drugs of abuse and HIV infection/replication: implications for mother-fetus transmission.
    Life Sci, 88(21): 972-9. [Abstract] [Full-text]
71. Nightlife young risk behaviours in Mediterranean versus other European cities: are stereotypes true?
    Eur J Public Health, 21(3): 311-5. [Abstract] [Full-text]
72. Attempted ignition of petrol vapour by lit cigarettes and lit cannabis resin joints.
    Sci Justice, 51(2): 72-6. [Abstract] [Full-text]
73. A postal intervention for dependent cannabis users.
    Drug Alcohol Rev. [Abstract] [Full-text]
74. Neurochemical alterations in adolescent chronic marijuana smokers: a proton MRS study.
    Neuroimage, 57(1): 69-75. [Abstract] [Full-text]
75. Preliminary evidence for associations of CHRM2 with substance use and disinhibition in adolescence.
    J Abnorm Child Psychol, 39(5): 671-81. [Abstract] [Full-text]
76. Persistent nonmedical use of prescription stimulants among college students: possible association with ADHD symptoms.
    J Atten Disord, 15(5): 347-56. [Abstract] [Full-text]
77. Prospective memory functioning among ecstasy/polydrug users: evidence from the Cambridge Prospective Memory Test (CAMPROMPT).
    Psychopharmacology (Berl), 215(4): 761-74. [Abstract] [Full-text]
78. Cannabinoid administration attenuates the progression of simian immunodeficiency virus.
    AIDS Res Hum Retroviruses, 27(6): 585-92. [Abstract] [Full-text]
79. Neuroanatomical substrates involved in cannabinoid modulation of defensive responses.
    J Psychopharmacol. [Abstract] [Full-text]
80. Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis.
    Eur Psychiatry. [Abstract] [Full-text]
81. Do Swiss adolescents perceive the negative effects of their illegal substance use?
    Swiss Med Wkly, 141: w13194. [Abstract] [Full-text]
82. History of abuse and neglect in patients with schizophrenia who have a history of violence.
    Child Abuse Negl, 35(5): 329-32. [Abstract] [Full-text]
83. Cannabis use, ischemic stroke, and multifocal intracranial vasoconstriction: a prospective study in 48 consecutive young patients.
    Stroke, 42(6): 1778-80. [Abstract] [Full-text]
84. Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine.
    Anal Chem, 83(11): 4228-36. [Abstract] [Full-text]
85. CB-1 receptors modulate the effect of the selective serotonin reuptake inhibitor, citalopram on extracellular serotonin levels in the rat prefrontal cortex.
    Neurosci Res, 70(3): 334-7. [Abstract] [Full-text]
86. Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial.
    Drug Alcohol Depend, 116(1): 142-50. [Abstract] [Full-text]
87. Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC.
    Drug Alcohol Depend, 116(1): 86-92. [Abstract] [Full-text]
88. Cannabis use and development of externalizing and internalizing behaviour problems in early adolescence: A TRAILS study.
    Drug Alcohol Depend, 116(1): 11-7. [Abstract] [Full-text]
89. Failure to sustain prepulse inhibition in adolescent marijuana users.
    Drug Alcohol Depend, 116(1): 110-6. [Abstract] [Full-text]

© 2004-2011 Marijuana Research Today. All Rights Reserved.